Healthcare and health situation of adults with type 2 diabetes in Germany: The study GEDA 2021/2022-Diabetes

J Health Monit. 2024 Jun 19;9(2):e12128. doi: 10.25646/12128. eCollection 2024 Jun.

Abstract

Background: The nationwide study German Health Update (GEDA) 2021/2022-Diabetes was conducted to assess the current healthcare and health situation of adults with diabetes in Germany.

Methods: GEDA 2021/2022-Diabetes comprises a sample of adults with diagnosed diabetes from the general population. The analysis focuses on adults aged 45 years and over with type 2 diabetes (N = 1,448) and provides selected indicators on diabetes care as well as mental, social and general health.

Results: 87.5 % of participants aged 45 years and over with type 2 diabetes are treated with blood glucose-lowering medication. 36.5 % receive insulin alone or in combination with other antidiabetics; 0.7 % use an insulin pump. Almost 96 % had an HbA1c measurement in the last year and about two thirds each report annual foot and eye examinations, participation in a diabetes self-management education programme and self-monitoring of their feet and of blood glucose (12.0 % with continuous glucose monitoring). On average, the quality of diabetes care is perceived as moderate. 23.8 % rate their mental health as excellent/very good. More than a tenth each have anxiety or depressive symptoms and feelings of loneliness. Half rate their general health as very good/good.

Conclusions: There is a potential for improvement in the quality of diabetes care and the mental and physical health of adults with type 2 diabetes.

Keywords: COVID-19; Diabetes mellitus; Germany; Health; Psyche; Surveillance; Treatment.

Grants and funding

The study GEDA 2021/2022-Diabetes was conducted as part of the National Diabetes Surveillance project at the Robert Koch Institute and funded by the Federal Ministry of Health (funding reference: 2522DIA700).